SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002049
Filing Date
2015-10-29
Accepted
2015-10-29 16:41:45
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20150930x10q.htm 10-Q 977338
2 EX-10.1 mrns-20150930ex10187772d.htm EX-10.1 31513
3 EX-10.2 mrns-20150930ex102ce6088.htm EX-10.2 32248
4 EX-31.1 mrns-20150930ex311e57944.htm EX-31.1 16317
5 EX-31.2 mrns-20150930ex312402c58.htm EX-31.2 16896
6 EX-32.1 mrns-20150930ex3213c26eb.htm EX-32.1 10408
7 GRAPHIC mrns20150930x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-15-002049.txt   2820126

Data Files

Seq Description Document Type Size
8 EX-101.INS mrns-20150930.xml EX-101.INS 365774
9 EX-101.SCH mrns-20150930.xsd EX-101.SCH 18940
10 EX-101.CAL mrns-20150930_cal.xml EX-101.CAL 30187
11 EX-101.DEF mrns-20150930_def.xml EX-101.DEF 51193
12 EX-101.LAB mrns-20150930_lab.xml EX-101.LAB 207565
13 EX-101.PRE mrns-20150930_pre.xml EX-101.PRE 138338
Mailing Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087
Business Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 151184248
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences